Top Markets
Coin of the day
Jenscare Scientific Co., Ltd. Jenscare Scientific Co., Ltd.

Jenscare Scientific Co., Ltd.

9877
Rank in Stocks #15054
Jenscare Scientific Co., Ltd. operates as a medical technology enterprise... Jenscare Scientific Co., Ltd. operates as a medical technology enterprise dedicated to advancing interventional therapies for structural heart conditions within the People's Republic of China. Among its pipeline, the company features LuX-Valve, an investigational transcatheter tricuspid valve replacement (TTVR) system designed for patients suffering from severe tricuspid regurgitation who face elevated surgical risks. Additionally, Ken-Valve represents another key product candidate, a transcatheter aortic valve replacement (TAVR) aimed at addressing severe aortic regurgitation, often co-occurring with aortic stenosis. The applications of Jenscare's portfolio extend to a range of structural cardiac maladies, including disorders of the tricuspid, aortic, and mitral valves, as well as heart failure. Founded in 2011, the company maintains its principal place of business in Ningbo, People's Republic of China.
Share Price
$0.90187992
Market Cap
$376.23M
Change (1 day)
-2.69%
Change (1 year)
-14.56%
Country
CN
Trade Jenscare Scientific Co., Ltd. (9877)

Category

Earnings for Jenscare Scientific Co., Ltd. (9877)
Earnings in 2026 TTM: 0
According to Jenscare Scientific Co., Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Jenscare Scientific Co., Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors